Protocol summary and statistical analysis plan for the low oxygen intervention for cardiac arrest injury limitation (LOGICAL) trial.

Cardiac arrest Hyperoxia Hypoxia Hypoxic ischaemic encephalopathy Oxygen therapy

Journal

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
ISSN: 1441-2772
Titre abrégé: Crit Care Resusc
Pays: Netherlands
ID NLM: 100888170

Informations de publication

Date de publication:
Sep 2023
Historique:
medline: 25 10 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

The effect of conservative vs. liberal oxygen therapy on outcomes of intensive care unit (ICU) patients with hypoxic ischaemic encephalopathy (HIE) is uncertain and will be evaluated in the Low Oxygen Intervention for Cardiac Arrest injury Limitation (LOGICAL) trial. The objective of this study was to summarise the protocol and statistical analysis plans for the LOGICAL trial. LOGICAL is a randomised clinical trial in adults in the ICU who are comatose with suspected HIE (i.e., those who have not obeyed commands following return of spontaneous circulation after a cardiac arrest where there is clinical concern about possible brain damage). The LOGICAL trial will include 1400 participants and is being conducted as a substudy of the Mega Randomised registry trial comparing conservative vs. liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU (Mega-ROX). The primary outcome is survival with favourable neurological function at 180 days after randomisation as measured with the Extended Glasgow Outcome Scale (GOS-E). A favourable neurological outcome will be defined as a GOS-E score of lower moderate disability or better (i.e. a GOS-E score of 5-8). Secondary outcomes include survival time, day 180 mortality, duration of invasive mechanical ventilation, ICU length of stay, hospital length of stay, the proportion of patients discharged home, quality of life assessed at day 180 using the EQ-5D-5L, and cognitive function assessed at day 180 using the Montreal Cognitive Assessment (MoCA-blind). The LOGICAL trial will provide reliable data on the impact of conservative vs. liberal oxygen therapy in ICU patients with suspected HIE following resuscitation from a cardiac arrest. Prepublication of the LOGICAL protocol and statistical analysis plan prior to trial conclusion will reduce the potential for outcome-reporting or analysis bias. Australian and New Zealand Clinical Trials Registry (ACTRN12621000518864).

Sections du résumé

Background UNASSIGNED
The effect of conservative vs. liberal oxygen therapy on outcomes of intensive care unit (ICU) patients with hypoxic ischaemic encephalopathy (HIE) is uncertain and will be evaluated in the Low Oxygen Intervention for Cardiac Arrest injury Limitation (LOGICAL) trial.
Objective UNASSIGNED
The objective of this study was to summarise the protocol and statistical analysis plans for the LOGICAL trial.
Design setting and participants UNASSIGNED
LOGICAL is a randomised clinical trial in adults in the ICU who are comatose with suspected HIE (i.e., those who have not obeyed commands following return of spontaneous circulation after a cardiac arrest where there is clinical concern about possible brain damage). The LOGICAL trial will include 1400 participants and is being conducted as a substudy of the Mega Randomised registry trial comparing conservative vs. liberal oxygenation targets in adults receiving unplanned invasive mechanical ventilation in the ICU (Mega-ROX).
Main outcome measures UNASSIGNED
The primary outcome is survival with favourable neurological function at 180 days after randomisation as measured with the Extended Glasgow Outcome Scale (GOS-E). A favourable neurological outcome will be defined as a GOS-E score of lower moderate disability or better (i.e. a GOS-E score of 5-8). Secondary outcomes include survival time, day 180 mortality, duration of invasive mechanical ventilation, ICU length of stay, hospital length of stay, the proportion of patients discharged home, quality of life assessed at day 180 using the EQ-5D-5L, and cognitive function assessed at day 180 using the Montreal Cognitive Assessment (MoCA-blind).
Conclusions UNASSIGNED
The LOGICAL trial will provide reliable data on the impact of conservative vs. liberal oxygen therapy in ICU patients with suspected HIE following resuscitation from a cardiac arrest. Prepublication of the LOGICAL protocol and statistical analysis plan prior to trial conclusion will reduce the potential for outcome-reporting or analysis bias.
Trial registration UNASSIGNED
Australian and New Zealand Clinical Trials Registry (ACTRN12621000518864).

Identifiants

pubmed: 37876368
doi: 10.1016/j.ccrj.2023.06.007
pii: S1441-2772(23)00028-5
pmc: PMC10581260
doi:

Types de publication

Journal Article

Langues

eng

Pagination

140-146

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

Rinaldo Bellomo, Paul Young, Carol Hodgson, Andrew Udy, Adam Deane and Ed Litton declare a conflict of interest as Editors or Editorial Committee members of this journal.

Références

Resuscitation. 2020 May;150:104-112
pubmed: 32205155
Crit Care. 2017 Apr 13;21(1):90
pubmed: 28403909
Stat Med. 2011 Nov 30;30(27):3192-207
pubmed: 21948462
N Engl J Med. 2022 Oct 20;387(16):1467-1476
pubmed: 36027567
N Engl J Med. 2014 Apr 3;370(14):1359
pubmed: 24693907
JAMA. 2022 Nov 8;328(18):1818-1826
pubmed: 36286192
Crit Care Med. 2021 Oct 1;49(10):e1040-e1042
pubmed: 34529620
Crit Care Med. 2018 Nov;46(11):1722-1730
pubmed: 30063490
Resuscitation. 2012 Apr;83(4):417-22
pubmed: 22226734
N Engl J Med. 2020 Mar 12;382(11):989-998
pubmed: 31613432
Intensive Care Med. 2020 Dec;46(12):2411-2422
pubmed: 32809136
Resuscitation. 2020 Dec;157:15-22
pubmed: 33058991

Auteurs

Paul J Young (PJ)

Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
Medical Research Institute of New Zealand, Wellington, New Zealand.
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.

Carol L Hodgson (CL)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.

Diane Mackle (D)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Anne M Mather (AM)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Richard Beasley (R)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Rinaldo Bellomo (R)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Victoria, Australia.

Stephen Bernard (S)

Department of Intensive Care & Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Department of Intensive Care, Victorian Heart Hospital, Melbourne, Victoria, Australia.

Kathy Brickell (K)

University College Dublin Clinical Research Centre at St Vincents University Hospital, Dublin, Ireland.

Adam M Deane (AM)

Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
Department of Intensive Care, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

Glenn Eastwood (G)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.

Simon Finfer (S)

The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Faculty of Medicine, University College London, London, United Kingdom.

Alisa M Higgins (AM)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Anna Hunt (A)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Cassie Lawrence (C)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Natalie J Linke (NJ)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Edward Litton (E)

School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Intensive Care Unit, Fiona Stanley Hospital, Robin Warren Drive, Murdoch, Western Australia, Australia.

Christine F McDonald (CF)

Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Victoria, Australia.
Faculty of Medicine, University of Melbourne, Victoria, Australia.
Institute for Breathing and Sleep, Melbourne, Victoria, Australia.

James Moore (J)

Intensive Care Unit, Wellington Hospital, Wellington, New Zealand.
Medical Research Institute of New Zealand, Wellington, New Zealand.

Alistair D Nichol (AD)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Intensive Care & Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
University College Dublin Clinical Research Centre at St Vincent's University Hospital, Dublin, Ireland.

Shaanti Olatunji (S)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Rachael L Parke (RL)

Medical Research Institute of New Zealand, Wellington, New Zealand.
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Cardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand.
School of Nursing, The University of Auckland, Auckland, New Zealand.

Sandra Peake (S)

Medical Research Institute of New Zealand, Wellington, New Zealand.
Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Paul Secombe (P)

Intensive Care Unit, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.

Ian M Seppelt (IM)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Intensive Care Unit, Nepean Hospital, Sydney, New South Wales, Australia.

Anne Turner (A)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Tony Trapani (T)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Andrew Udy (A)

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
Department of Intensive Care & Hyperbaric Medicine, Alfred Hospital, Melbourne, Victoria, Australia.

Jessica Kasza (J)

School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

Classifications MeSH